Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
Rong Huang, Yu Pu, Shun Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides
Jacopo Millul, Lennart Koepke, Gaonkar Raghuvir Haridas, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 10, pp. 3050-3061
Open Access | Times Cited: 37
One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study
Guobing Liu, Wujian Mao, Haojun Yu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 8, pp. 2271-2281
Closed Access | Times Cited: 23
Clinical Theranostics in Recurrent Gliomas: A Review
Austin R. Hoggarth, Sankar Muthukumar, Steven Thomas, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1715-1715
Open Access | Times Cited: 10
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET/CT in common gynecological malignancies
Tengfei Li, Jintao Zhang, Yuanzhuo Yan, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT
Shaghayegh Nourbakhsh, Yalda Salehi, Saeed Farzanehfar, et al.
Nuklearmedizin - NuclearMedicine (2024)
Closed Access | Times Cited: 7
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine
Ayaka Aso, Hinako Nabetani, Yoshifumi Matsuura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8701-8701
Open Access | Times Cited: 16
FAPI PET/CT in Diagnostic and Treatment Management of Colorectal Cancer: Review of Current Research Status
Zhiming Cheng, Shu Wang, Shuoyan Xu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 577-577
Open Access | Times Cited: 15
Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers
Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 1, pp. 233-244
Closed Access | Times Cited: 14
A cysteine/lipid droplets sequentially activated dual-locked fluorescent probe for accurate bioimaging of tumor tissues
Yibo Huang, Hongliang Xu, Ermei Lu, et al.
Dyes and Pigments (2024) Vol. 224, pp. 112001-112001
Closed Access | Times Cited: 6
Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 345-345
Open Access | Times Cited: 6
Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics
Masayuki Munekane, Takeshi Fuchigami, Kazuma Ogawa
Analytical Sciences (2024) Vol. 40, Iss. 5, pp. 803-826
Open Access | Times Cited: 6
Current Developments in Diagnosis of Salivary Gland Tumors: From Structure to Artificial Intelligence
Alexandra Corina Faur, Roxana Buzaș, Adrian Emil Lăzărescu, et al.
Life (2024) Vol. 14, Iss. 6, pp. 727-727
Open Access | Times Cited: 6
Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts
Raisa A. Glabman, Colleen Olkowski, Hannah A. Minor, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 449-449
Open Access | Times Cited: 5
Advances in the Development of Positron Emission Tomography Tracers for Improved Detection of Differentiated Thyroid Cancer
Hannelore I. Coerts, Bart de Keizer, Frederik A. Verburg
Cancers (2024) Vol. 16, Iss. 7, pp. 1401-1401
Open Access | Times Cited: 4
Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT
Joyce van Sluis, Ronald Borra, Charalampos Tsoumpas, et al.
Cancer Imaging (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients
Jeremy McGale, Sakshi Khurana, Harrison Howell, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library
Gihan S. Gunaratne, Joseph P. Gallant, Kendahl L. Ott, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Radiotheranostic landscape: A review of clinical and preclinical development
Huyen Tran, Aiko Yamaguchi, H. Charles Manning
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Eliminating the second CT scan of dual-tracer total-body PET/CT via deep learning-based image synthesis and registration
Yu Lin, Kang Wang, Zhe Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons
Divya Yadav, Elisabeth O’Dwyer, Matthew Agee, et al.
Journal of Imaging (2025) Vol. 11, Iss. 2, pp. 63-63
Open Access
A Novel 68Ga‐Labeled 2‐Azabicyclo[3.1.0]Hexane‐3‐Carbonitrile‐Based Fibroblast Activation Protein‐Targeted Tracer for Cancer Imaging With Positron Emission Tomography
Chao‐Cheng Chen, Lei Wang, Antonio A. W. L. Wong, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2025) Vol. 68, Iss. 3
Closed Access
Advances in PET imaging of fibroblast activating protein inhibitors for the diagnosis of common malignant tumors
Wenfang Liao, Bao Zhu, Bao Zhu
Journal of Radioanalytical and Nuclear Chemistry (2025)
Closed Access
Incoming novel radiotracer development: Fibroblast activation protein inhibitors for cancer diagnosis and treatment
Lakshmi Madhusoodanan, Benjamin L. Viglianti, Peter J. H. Scott
Seminars in Roentgenology (2025)
Closed Access
Nuclear Medicine in Oncology
Dikhra Khan, Rakesh Kumar, Nilendu Purandare
(2025), pp. 655-712
Closed Access
Page 1 - Next Page

Scroll to top